Advertisement
U.S. Markets closed

Dignitana AB (publ) (DIGN.ST)

Stockholm - Stockholm Real Time Price. Currency in SEK
1.9900+0.1200 (+6.42%)
At close: 12:59PM CET
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.8700
Open1.8400
Bid1.9250 x 0
Ask1.9400 x 0
Day's Range1.8400 - 1.9900
52 Week Range1.3050 - 5.0000
Volume12,214
Avg. Volume19,229
Market Cap140.244M
Beta (5Y Monthly)1.36
PE Ratio (TTM)N/A
EPS (TTM)-0.3300
Earnings DateMay 23, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est9.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for DIGN.ST

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • PR Newswire

      Dignitana signs OncoMedical for distribution in Switzerland and Liechtenstein

      Scalp cooling innovator Dignitana AB has signed OncoMedical AG as the exclusive distributor for The DigniCap Scalp Cooling System in Switzerland and Liechtenstein. OncoMedical specializes in medical technology products in the areas of oncology, pain therapy and palliative care. OncoMedical will purchase at least eight DigniCap Delta devices and the corresponding patient consumables in 2024 to launch the product which minimizes hair loss from chemotherapy, with the first order for three devices s

    • PR Newswire

      Dignitana announces a sales and marketing partnership with InfuSystem to provide scalp cooling systems in the United States

      Scalp cooling innovator Dignitana AB announces today a sales and marketing partnership with InfuSystem Holdings, Inc., a leading health care service provider facilitating outpatient care for durable medical equipment manufacturers and health care providers in the United States.

    • PR Newswire

      Dignitana Announces Palmetto GBA Approves First Local Coverage Determination for Scalp Cooling Therapy

      Dignitana announces that the Palmetto GBA Medicare Administrative Contractor (MAC) has issued a Local Coverage Determination (LCD) to provide coverage guidance for Scalp Cooling for the Prevention of Chemotherapy-Induced Alopecia. According to the final LCD guidance from Palmetto GBA, "the use of a scalp hypothermia device that has been approved by the United States (U.S.) Food and Drug Administration (FDA) for the prevention of chemotherapy-induced alopecia (CIA) shall be considered reasonable